J Neurol Surg B Skull Base 2021; 82(S 03): e22-e32
DOI: 10.1055/s-0040-1701676
Original Article

The Clinical Implications of Spontaneous Hemorrhage in Vestibular Schwannomas

Christopher S. Hong
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Lan Jin
2   Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Wyatt B. David
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Brian Shear
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Amy Y. Zhao
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Yawei Zhang
2   Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States
,
E. Zeynep Erson-Omay
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Robert K. Fulbright
3   Department of Radiology, Yale School of Medicine, New Haven, Connecticut, United States
,
Anita Huttner
4   Department of Pathology, Yale School of Medicine, New Haven, Connecticut, United States
,
John Kveton
5   Division of Otolaryngology, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, United States
,
Jennifer Moliterno
1   Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, United States
› Author Affiliations

Abstract

Background Spontaneous hemorrhage into vestibular schwannomas (VSs) is rare and can render more rapid symptom onset and a seemingly poorer prognosis for an otherwise benign pathology. We describe our series of hemorrhagic VS (HVSs) and systematically reviewed the literature to better understand relevant clinical factors and outcomes.

Methods Retrospective case review series and systematic review of the literature using PRISMA guidelines.

Results Fifty-three patients with HVS met inclusion criteria. Compared with historical data for all VS, patients with HVS had relatively higher rates of perioperative mortality, significant preoperative facial weakness, and harbored relatively larger tumors. Regardless of the extent of resection (EOR), surgery for HVS resulted in significant improvement of facial weakness (p = 0.041), facial numbness (p < 0.001), vertigo (p < 0.001), and headache (p < 0.001). Patients with facial weakness tended to have larger tumors (p = 0.058) on average and demonstrated significant improvement after surgery, irrespective of EOR (p < 0.01). The use of blood-thinning medications did not affect patient health outcome. Histopathology of HVS samples showed an increased number of dilated/ectatic thin-walled vascular channels, reflective of potentially increased vascular permeability and hypervascularity.

Conclusion HVS may be an aggressive subgroup of VS, associated with a surprisingly high mortality rate. When features of HVS are identified on imaging, these patients should be treated expeditiously, especially given that facial nerve dysfunction, which is identified in more than half of patients with HVS, appears to be reversible. Overall, this study has significant implications in the management of VS, raising awareness of a small, but highly morbid subgroup.

Supplementary Material



Publication History

Received: 18 September 2019

Accepted: 31 December 2019

Article published online:
16 March 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Incidence of vestibular schwannomas in the United States. J Neurooncol 2015; 124 (02) 223-228
  • 2 Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro-oncol 2018; 20 (Suppl. 04) iv1-iv86
  • 3 Halliday J, Rutherford SA, McCabe MG, Evans DG. An update on the diagnosis and treatment of vestibular schwannoma. Expert Rev Neurother 2018; 18 (01) 29-39
  • 4 Stangerup SE, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 2012; 45 (02) 257-268 , vii
  • 5 Niknafs YS, Wang AC, Than KD, Etame AB, Thompson BG, Sullivan SE. Hemorrhagic vestibular schwannoma: review of the literature. World Neurosurg 2014; 82 (05) 751-756
  • 6 Hatch JL, Bauschard MJ, Nguyen SA, Lambert PR, Meyer TA, McRackan TR. National trends in vestibular schwannoma surgery: influence of patient characteristics on outcomes. Otolaryngol Head Neck Surg 2018; 159 (01) 102-109
  • 7 McClelland III S, Kim E, Murphy JD, Jaboin JJ. Operative mortality rates of acoustic neuroma surgery: a National Cancer Database analysis. Otol Neurotol 2017; 38 (05) 751-753
  • 8 Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery 1997; 40 (01) 1-9
  • 9 Torres Maldonado S, Naples JG, Fathy R. et al. Recent trends in vestibular schwannoma management: an 11-year analysis of the National Cancer Database. Otolaryngol Head Neck Surg 2019; 161 (01) 137-143
  • 10 Tos M, Stangerup SE, Cayé-Thomasen P, Tos T, Thomsen J. What is the real incidence of vestibular schwannoma?. Arch Otolaryngol Head Neck Surg 2004; 130 (02) 216-220
  • 11 Benhaiem-Sigaux N, Ricolfi F, Torres-Díaz A, Keravel Y, Poirier J. Haemorrhagic acoustic neuroma with features of a vascular malformation. A case report. Neuroradiology 1999; 41 (10) 795-798
  • 12 Dehdashti AR, Kiehl TR, Guha A. Vestibular schwannomas presenting with haemorrhage: clinical presentation and histopathological evaluation of an unusual entity. Br J Neurosurg 2009; 23 (04) 431-436
  • 13 Cayé-Thomasen P, Baandrup L, Jacobsen GK, Thomsen J, Stangerup SE. Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate. Laryngoscope 2003; 113 (12) 2129-2134
  • 14 Cayé-Thomasen P, Werther K, Nalla A. et al. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005; 26 (01) 98-101
  • 15 Alanin MC, Klausen C, Caye-Thomasen P. et al. The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2. Eur Arch Otorhinolaryngol 2015; 272 (12) 3627-3633
  • 16 Mautner VF, Nguyen R, Kutta H. et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro-oncol 2010; 12 (01) 14-18
  • 17 Plotkin SR, Merker VL, Halpin C. et al. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 2012; 33 (06) 1046-1052
  • 18 Plotkin SR, Stemmer-Rachamimov AO, Barker II FG. et al. Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361 (04) 358-367
  • 19 Banaama S, van Overbeeke J, Temel Y. An unusual case of repeated intracranial hemorrhage in vestibular schwannoma. Surg Neurol Int 2016; 7 (Suppl. 37) S869-S871
  • 20 Carlson ML, Tombers NM, Driscoll CLW. et al. Clinically significant intratumoral hemorrhage in patients with vestibular schwannoma. Laryngoscope 2017; 127 (06) 1420-1426
  • 21 Schlieter M, Zoubaa S, Kress B, Unterberg A, Jacobi C, Hähnel S. Hemorrhagic acoustic schwannoma: radiological and histopathological findings. J Neuroradiol 2005; 32 (03) 210-212
  • 22 Vellin JF, Bozorg Grayeli A, Kalamarides M, Fond C, Bouccara D, Sterkers O. Intratumoral and brainstem hemorrhage in a patient with vestibular schwannoma and oral anticoagulant therapy. Otol Neurotol 2006; 27 (02) 209-212
  • 23 Yates CW, Weinberg M, Packer MJ, Jacob A. Fatal case of tumor-associated hemorrhage in a large vestibular schwannoma. Ann Otol Rhinol Laryngol 2010; 119 (06) 402-405
  • 24 Fatehi Hassanabad M, Akagami R. Sudden neurological deterioration due to repeated intratumoral hemorrhage in a patient with a vestibular schwannoma. J Clin Neurosci 2019; 61: 304-307
  • 25 Yang X, Liu J, Zhang Y, Richard SA. Tumor-associated hemorrhage in patients with vestibular schwannoma. Acta Neurochir (Wien) 2018; 160 (08) 1563-1569
  • 26 Takeuchi S, Nawashiro H, Otani N. et al. Vestibular schwannoma with repeated intratumoral hemorrhage. J Clin Neurosci 2012; 19 (09) 1305-1307
  • 27 Castillo R, Watts C, Pulliam M. Sudden hemorrhage in an acoustic neuroma. Case report. J Neurosurg 1982; 56 (03) 417-419
  • 28 Gleeson RK, Butzer JF, Grin Jr OD. Acoustic neurinoma presenting as subarachnoid hemorrhage. Case report. J Neurosurg 1978; 49 (04) 602-604
  • 29 Yonemitsu T, Niizuma H, Kodama N, Fujiwara S, Suzuki J. Acoustic neurinoma presenting as subarachnoid hemorrhage. Surg Neurol 1983; 20 (02) 125-130
  • 30 Goetting MG, Swanson SE. Massive hemorrhage into intracranial neurinomas. Surg Neurol 1987; 27 (02) 168-172
  • 31 Kodama T, Matsukado Y, Takamoto K. Acoustic schwannoma presenting as subarachnoid hemorrhage due to ruptured contact aneurysm. Surg Neurol 1987; 27 (01) 77-80
  • 32 Kojima Y, Tanaka N, Kuwana N. Massive hemorrhage in acoustic neurinoma after minor head trauma--case report. Neurol Med Chir (Tokyo) 1990; 30 (12) 972-976
  • 33 Spickler E, Lufkin R, Teresi L. et al. MR of hemorrhagic acoustic neuromas. Comput Med Imaging Graph 1991; 15 (05) 333-337
  • 34 Asari S, Katayama S, Itoh T, Tsuchida S, Ohmoto T. CT and MRI of haemorrhage into intracranial neuromas. Neuroradiology 1993; 35 (04) 247-250
  • 35 Lessin BD, Alenghat JP. Magnetic resonance imaging of hemorrhagic acoustic neuroma. Clin Imaging 1993; 17 (02) 142-145
  • 36 Brady AP, Stack JP. Case report: magnetic resonance demonstration of haemorrhagic acoustic neuroma. Clin Radiol 1994; 49 (01) 61-63
  • 37 Tomono Y, Takeuchi S, Nose T. Acoustic neurinoma with a large organized hematoma--case report. Neurol Med Chir (Tokyo) 1996; 36 (06) 380-383
  • 38 Kim SH, Youm JY, Song SH, Kim Y, Song KS. Vestibular schwannoma with repeated intratumoral hemorrhage. Clin Neurol Neurosurg 1998; 100 (01) 68-74
  • 39 Ohta S, Yokoyama T, Nishizawa S. Massive haemorrhage into acoustic neurinoma related to rapid growth of the tumour. Br J Neurosurg 1998; 12 (05) 455-457
  • 40 Sugihara S, Kinoshita T, Matsusue E, Fujii S, Ogawa T. Multicystic acoustic schwannoma with intratumoral hemorrhage: a report of two cases. Magn Reson Med Sci 2004; 3 (02) 101-104
  • 41 Chu M, Wei LL, Li GZ, Lin YZ, Zhao SG. Bilateral acoustic neurinomas presenting as subarachnoid hemorrhage: case report. Chin Med J (Engl) 2007; 120 (01) 83-84
  • 42 Carlson ML, Driscoll CL, Link MJ, Inwards CY, Neff BA, Beatty CW. A hemorrhagic vestibular schwannoma presenting with rapid neurologic decline: a case report. Laryngoscope 2010; 120 (Suppl. 04) S204
  • 43 Gavra M, Thanos L, Pomoni M, Batakis N. Spontaneous subarachnoid haemorrhage due to acoustic neurinoma. Case report and review of the literature. Br J Neurosurg 2010; 24 (01) 82-83
  • 44 Maimone G, Ganau M, Nicassio N, Cambria M. Clinical and radiological aspects of cerebellopontine neurinoma presenting with recurrent spontaneous bleedings. Surg Neurol Int 2013; 4: 67